Viragen Reports on Multiferon Anti-Viral Studies with U.S. Army Researchers
In this research collaboration, Viragen and USAMRIID have agreed to conduct a study program designed to evaluate Multiferon® against specific viral agents. Additional studies will evaluate Multiferon® as a possible broad-acting anti-viral product, which may be used as a first-line of defense against unknown infectious agents or when no therapeutic or vaccine exists. These studies are expected to be completed by this summer and will help determine the potential role of Multiferon® as a bio-defense product.
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.